Atlas Trials

Direct Oral Novel Anticoagulants for Patients With High-risk Gastroesophageal Variceal Bleeding and Portal Vein Thrombosis

Clinical trial NCT07602062 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07602062
Sponsor
Shanghai Zhongshan Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Portal Vein ThrombosisAnticoagulant TherapyVariceal Bleeding
Start date
2026-06-01
Primary completion
2027-12-31
Enrollment
175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.